TeleTrader 11/3/2022 Amgen sees EPS soaring 20% to $3.98 in Q3
TeleTrader 11/3/2022 US closes lower ahead of another batch of earnings
TeleTrader 11/3/2022 Wall Street opens lower after Fed hikes rate again
TeleTrader 10/24/2022 US closes higher with major earnings reports in focus
TeleTrader 10/24/2022 Wall Street extends gains, Dow soars 500 points
TeleTrader 10/24/2022 US markets open mostly higher amid earnings releases
TeleTrader 10/19/2022 Dow falls 250 pts as Wall Street changes course again
TeleTrader 10/11/2022 Wall Street closes mostly lower after BoE warning
TeleTrader 8/31/2022 US opens higher with economy in focus
TeleTrader 8/4/2022 Amgen's Q2 EPS triples to $2.45
TeleTrader 8/4/2022 US closes mostly lower after labor market data
TeleTrader 8/4/2022 US opens mostly flat after trade, jobs data
TeleTrader 6/2/2022 Wall Street opens lower amid data
GlobeNewswire 3/23/2022 CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of Directors
GlobeNewswire 3/23/2022 OcyonBio Client Biosimilar Solutions, Inc. Initiates Registrational Clinical Trial for Its First Bio...
GlobeNewswire 3/21/2022 Chinook Therapeutics Announces Appointment of Dr. Mahesh Krishnan to its Board of Directors
GlobeNewswire 3/17/2022 CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program...
GlobeNewswire 3/15/2022 Molecular Partners Reports Corporate Highlights From Q4 2021 and Key Financials for Full Year 2021
GlobeNewswire 3/15/2022 Coherus BioSciences Appoints Rosh Dias, MD, MRCP, Chief Medical Officer
GlobeNewswire 3/9/2022 Sensei Biotherapeutics Appoints William Ringo, MBA, as Chair of Board of Directors
GlobeNewswire 3/8/2022 Entera Bio Reports Financial Results for the Year Ended December 31, 2021
GlobeNewswire 3/3/2022 IO Biotech Announces Appointment of David V. Smith to its Board of Directors
GlobeNewswire 3/3/2022 Entera Bio to Report Business and Financial Results for the Year Ended December 31, 2021 on March 8,...
GlobeNewswire 3/2/2022 AmMax Bio Announces Positive Phase 2 Results Demonstrating Proof-of-Concept for the Novel Local Deli...
GlobeNewswire 3/1/2022 CytomX Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results, and Provides Busine...